Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: a Pilot Phase I/II Feasibility Study

Por Einbeigi, Z., Bergström, D., Hatschek, T., Malmberg, M.
Publicado em 2008

Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis

Por Rohlin, A, Engwall, Y, Fritzell, K, Göransson, K, Bergsten, A, Einbeigi, Z, Nilbert, M, Karlsson, P, Björk, J, Nordling, M
Publicado em 2011

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

Por Tobin, N. P., Harrell, J. C., Lövrot, J., Egyhazi Brage, S., Frostvik Stolt, M., Carlsson, L., Einbeigi, Z., Linderholm, B., Loman, N., Malmberg, M., Walz, T., Fernö, M., Perou, C. M., Bergh, J., Hatschek, T., Lindström, L. S.
Publicado no Ann Oncol (2015)